Abivax SA (ABVX) — Cash Flow-to-Debt Ratio
Abivax SA (ABVX) has a Cash Flow-to-Debt Ratio of -0.55x as of December 2025, meaning its operating cash flow of €-71.28 Million could theoretically repay -1% of its total liabilities (€129.14 Million) in one year. See working capital to net assets of Abivax SA to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Abivax SA Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Abivax SA across 13 annual periods. Also explore net asset growth rate of Abivax SA to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Abivax SA (2013–2025)
Year-by-year debt coverage analysis for Abivax SA. For market capitalisation and broader financial context, see ABVX market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.26x | €-162.09 Million | €129.14 Million | ▼ -34.1% |
| 2024 | -0.94x | €-154.07 Million | €164.64 Million | ▼ -26.3% |
| 2023 | -0.74x | €-97.13 Million | €131.05 Million | ▲ +19.2% |
| 2022 | -0.92x | €-65.58 Million | €71.47 Million | ▼ -64.0% |
| 2021 | -0.56x | €-45.66 Million | €81.59 Million | ▼ -25.0% |
| 2020 | -0.45x | €-29.82 Million | €66.62 Million | ▲ +34.9% |
| 2019 | -0.69x | €-27.47 Million | €39.95 Million | ▲ +8.7% |
| 2018 | -0.75x | €-14.60 Million | €19.39 Million | ▲ +49.8% |
| 2017 | -1.50x | €-8.45 Million | €5.63 Million | ▲ +62.7% |
| 2016 | -4.02x | €-15.61 Million | €3.88 Million | ▼ -22.3% |
| 2015 | -3.29x | €-14.90 Million | €4.53 Million | ▼ -301.3% |
| 2014 | -0.82x | €-3.31 Million | €4.03 Million | ▼ -10.2% |
| 2013 | -0.74x | €-3.31 Million | €4.44 Million | — |